Month: April 2011

2nd Business Process Excellence for Pharmaceuticals, Biotech and Medical Devices (2 of 2)

Business Process Excellence for Pharmaceuticals, Biotech and Medical Devices, The Brewery, London, April 2011 (2 of 2) John Riddell and Elisabeth Goodman, RiverRhee Consulting1 For part 1 of this blog see: 2nd Business Process Excellence for Pharmaceuticals, Biotech and Medical Devices (1 of 2) http://wp.me/pAUbH-40 Application to ‘other’ environments (1): biotech Simon Orchard, Vice President Biotech Operations …

2nd Business Process Excellence for Pharmaceuticals, Biotech and Medical Devices (2 of 2) Read More »

2nd Business Process Excellence for Pharmaceuticals, Biotech and Medical Devices (1 of 2)

Business Process Excellence for Pharmaceuticals, Biotech and Medical Devices, The Brewery, London, April 2011 (1 of 2) John Riddell and Elisabeth Goodman, RiverRhee Consulting1 This was the second of IQPC’s specialist conferences on this theme, and as last time2, many of those questioned by the authors were finding it of real value for learning about …

2nd Business Process Excellence for Pharmaceuticals, Biotech and Medical Devices (1 of 2) Read More »

Why thinking in terms of burning platforms and tipping points is not sufficient to drive change

The term ‘burning platform’ has its origins in a real life/death scenario faced by an oil worker in the North Sea and now commonly used to help change agents and stakeholders articulate organisational or personal motivation (WIIFM – What’s In It For Me) for change. ‘Burning platforms’ form the basis of ‘sticky’ or unresistable messages …

Why thinking in terms of burning platforms and tipping points is not sufficient to drive change Read More »